<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-28T18:35:08Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/17165" metadataPrefix="qdc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/17165</identifier><datestamp>2026-02-03T12:24:08Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><qdc:qualifieddc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Cancer immunotherapy as a new treatment option</dc:title>
   <dc:creator>Burgos-Molina, Antonio Manuel</dc:creator>
   <dc:creator>Padín-López, Alba</dc:creator>
   <dc:creator>Alonso-Ortiz, Antonio</dc:creator>
   <dc:subject>Cancer - Tratamiento</dc:subject>
   <dcterms:abstract>Cancer can coaptate the immune control of the immune system (IS), evade immunity and its destruction.&#xd;
So, could we say openly that immunotherapy is a viable treatment option for patients with advanced&#xd;
cancer? Yes, immunotherapy would give us great advances in the war against cancer. Therefore, the&#xd;
development of a new generation of immune modulators (which have been analyzed in the following&#xd;
article) is necessary. In addition, these will be more effective if we use them in combination, taking&#xd;
advantage of their synergy.</dcterms:abstract>
   <dcterms:dateAccepted>2019-01-16T12:46:39Z</dcterms:dateAccepted>
   <dcterms:available>2019-01-16T12:46:39Z</dcterms:available>
   <dcterms:created>2019-01-16T12:46:39Z</dcterms:created>
   <dcterms:issued>2019-01-16</dcterms:issued>
   <dc:type>conference output</dc:type>
   <dc:identifier>https://hdl.handle.net/10630/17165</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>16th ASEICA International Congress 2018</dc:relation>
   <dc:relation>Valencia (España)</dc:relation>
   <dc:relation>06-08/11/2018</dc:relation>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
</qdc:qualifieddc>
</metadata></record></GetRecord></OAI-PMH>